Literature DB >> 107303

A clinical study of young infants after small intestinal resection.

T D Bohane, K Haka-Ikse, W D Biggar, J R Hamilton, D G Gall.   

Abstract

We prospectively studied 15 infants who, before 3 months of age, underwent resection of the small intestine-proximal in 3 infants, mid in 6, and distal in 6. Two died before one year of age. Many required prolonged parenteral nutrition, but by one year, 12 of the 13 survivors were on oral feedings only, and seven were above the third percentile for height and weight. Developmental delay occurred in the early postoperative period but diminished with time. There was compensatory adaptation of the remaining gut, shown by improving fat and B12 absorption and duodenal bile-salt concentrations. Bacterial contamination complicating end-to-side anastomoses occurred in two cases (P), gastric hyperacidity in four of 12 (1P, 3M), and hyperoxaluria in eight of 14 (1P, 5M, 2D). Studies of immune competence revealed normal cellular immune function (11/11), transient hypogammaglobulinemia (3/14), hypocomplementemia (1/12), and serum autoantibodies (3/10). Thus, massive resection of the small intestine did not preclude spontaneous improvement in absorptive function, growth, and development.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107303     DOI: 10.1016/s0022-3476(79)80009-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Enteral and parenteral nutrition in the short bowel syndrome in children.

Authors:  C Ricour; J F Duhamel; F Arnaud-Battandier; Y Collard; Y Revillon; C Nihoul-Fekete
Journal:  World J Surg       Date:  1985-04       Impact factor: 3.352

Review 2.  Short bowel syndrome.

Authors:  M D Stringer; J W Puntis
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

3.  Massive small bowel resection in neonates--is weaning from parenteral nutrition the final goal?

Authors:  Y Matsuo; R Nezu; A Kubota; M Fukuzawa; K Imura; S Kamata; Y Takagi; A Okada
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

4.  Augmentation of postresection mucosal hyperplasia by plerocercoid growth factor (PGF). Analog of human growth hormone.

Authors:  M H Hart; C K Phares; S H Erdman; C J Grandjean; J H Park; J A Vanderhoof
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.